Ms. Sandra A Bernstein, RN, MSN, CS, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 593 Bethlehem Pike, Suite 4b, Montgomeryville, PA 18936 Phone: 215-822-2224 Fax: 215-822-6999 |
News Archive
Star Scientific, Inc. announced that on Friday, June 18 the company filed an application with the Food & Drug Administration for approval to market Stonewall-BDL™ as a "modified risk tobacco product" under the Family Smoking Prevention and Tobacco Control Act of 2009. This is Star's second such application to the Tobacco Products Center of the FDA, which has been established to oversee all aspects of tobacco regulation outlined in the 2009 Act.
Results from a two-year eye health study - the first of its kind in the world – have shown a new hope for people suffering from age-related macular degeneration (AMD), the most common cause of sight loss in the UK.
New research shows that a small gene variation that increases the risk of inherited cancer can also arise during the development of spontaneous, or non-inherited, tumors.
Following the recent G20 side event co-hosted by the Italian Government and the United Nations World Food Programme (WFP) focusing on the role of logistics in current and future health emergencies, WFP and the World Health Organization (WHO) are launching INITIATE2, a joint project to bring together emergency actors, research and academic institutions, and international and national partners to promote knowledge sharing and skills transfer for improved emergency response to health crises.
A new study has been published on the medRxiv* preprint server, which focuses on the development of a dual-antigen COVID-19' T cell' vaccine. This vaccine is developed based on the expression of both S protein and nucleocapsid (N) protein of SARS-CoV-2, using a next-generation human adenovirus serotype 5 (Ad5) platform.
› Verified 4 days ago